We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Aspen

3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Telephone: 003531 630 8400
Medical Information Direct Line: 0080000404142 - Freephone
Medical Information e-mail: aspenmedinfo@professionalinformation.co.uk
Patient Information Leaflet last updated on medicines.ie: 12/09/2017
PIL Ultiva 1 mg, 2 mg, 5 mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - manufacturer
Updated on 15/08/2017 and displayed until 12/09/2017
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 20/07/2015 and displayed until 15/08/2017
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 15/07/2015 and displayed until 20/07/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 10/06/2015 and displayed until 15/07/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
  • Correction of spelling/typing errors
  • Improved electronic presentation
Updated on 30/01/2015 and displayed until 10/06/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 10/11/2011 and displayed until 30/01/2015
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/07/2011 and displayed until 10/11/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Correction of spelling/typing errors
Updated on 21/02/2011 and displayed until 15/07/2011
Reasons for adding or updating:
  • Change of active ingredient
  • Change to warnings or special precautions for use
  • Change to storage instructions
Updated on 04/08/2005 and displayed until 21/02/2011
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Remifentanil Hydrochloride